Friday, 23 March 2018

Pfizer's quit-smoking Chantix fails study in adolescent smokers

(Reuters) - Pfizer Inc said on Friday its study to test safety and effectiveness of its anti-smoking treatment Chantix in adolescent smokers failed to meet the main goal.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)